Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study

OMICS A Journal of Integrative Biology

Volumn 13, Issue 6, 2009, Pages 467-476

  Zhu, Fengjia ^a,b   Wang, Yi ^b,c   Zeng, Su ^b   Fu, Xiaoyun ^c   Wang, Linbo ^a   Cao, Jiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CELL PROTEIN; CHAPERONE; CISPLATIN; DOXORUBICIN; ENZYME; FLUOROURACIL; GLYCOPROTEIN P; IMATINIB; LIPOCORTIN 1; PROTEOME; VINCRISTINE;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CROSS RESISTANCE; DNA FRAGMENTATION; DNA SYNTHESIS; DOWN REGULATION; DRUG ACCUMULATION; DRUG SENSITIVITY; ERYTHROLEUKEMIA CELL; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANNEXIN A1; CALCIUM-BINDING PROTEINS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 73149108652     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2009.0046     Document Type: Article

References (32)

1. Abbott, B.L. (2003). ABCG2 (BCRP) expression in normal and malignant hematopoietic cells. Hematol Oncol 21, 115-130.
2. Arur, S., Uche, U.E., Rezaul, K., Fong, M., Scranton, V., Cowan, A.E., et al. (2003). Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 4, 587-598.
3. Auerbach, L., Hellan, M., Stierer, M., Rosen, A.C., Ausch, C., Obwegeser, R., et al. (1999). Identification of women with early breast cancer by analysis of p43-positive lymphocytes. Br J Cancer 80, 874-878.
4. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G.M., Carnemolla, B., et al. (2004). Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327-1333.
5. Chuthapisith, S., Layfield, R., Kerr, I.D., Hughes, C., and Eremin, O. (2007). Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int J Oncol 30, 1545-1551.
6. Debret, R., El Btaouri, H., Duca, L., Rahman, I., Radke, S., Haye, B., et al. (2003). Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 546, 195-202.
7. Garcia Pedrero, J.M., Fernandez, M.P., Morgan, R.O., Zapatero, A., Gonzalez, M.V., Suarez Nieto, C., et al. (2004). Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164, 73-79.
8. Gehrmann, M.L., Hathout, Y., Fenselau, C. (2004a). Evaluation of metabolic labeling for comparative proteomics in breast cancer cells. J Proteome Res 3, 1063-1068.
9. Gehrmann, M.L., Fenselau, C., and Hathout, Y. (2004b). Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line. J Proteome Res 3, 403-409.
10. Jiang, D., Ying, W., Lu, Y., Wan, J., Zhai, Y., Liu, W., et al. (2003). Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3, 724-737.
11. Kim, H.K., Park, W.S., Kang, S.H., Warda, M., Kim, N., Ko, J.H., et al. (2007). Mitochondrial alterations in human gastric carcinoma cell line. Am J Physiol Cell Physiol 293, C761-C771.
12. Kreunin, P., Yoo, C., Urquidi, V., Lubman, D.M., and Goodison, S. (2007). Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 7, 299-312.
13. Lanneau, D., Brunet, M., Frisan, E., Solary, E., Fontenay, M., and Garrido, C. (2008). Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12, 743-761.
14. Lim, L.H., and Pervaiz, S. (2007). Annexin 1: the new face of an old molecule. FASEB J 21, 968-975.
15. Mazurek, S., and Eigenbrodt, E. (2003). The tumor metabolome. Anticancer Res 23, 1149-1154.
16. Mazzella, F.M., Kowal-Vern, A., Shrit, M.A., Rector, J.T., Cotelingam, J.D., Schumacher, H.R. (2000). Effects of multidrug resistance gene expression in acute erythroleukemia. Mod Pathol 13, 407-413.
17. Menefee, M.E., Fan, C., Edgerly, M., Draper, D., Chen, C., Robey, R., et al. (2005). Tariquidar (XR9576) is a potent and effective P-glycoprotein (Pgp) inhibitor that can be administered safely with chemotherapy. J Clin Oncol 23(Suppl), 3093.
18. Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K.M., Carver, L.A., et al. (2004). Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429, 629-635.
19. Ozben, T. (2006). Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580, 2903-2909.
20. Parente, L., and Solito, E. (2004). Annexin 1, more than an antiphospholipase protein. Inflamm Res 53, 125-132.
21. Qi, Y., Chiu, J.F., Wang, L., Kwong, D.L., and He, Q.Y. (2005). Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5, 2960-2971.
22. Roviezzo, F., Getting, S.J., Paul-Clark, M.J., Yona, S., Gavins, F.N., Perretti, M., et al. (2002). The annexin-1 knockout mouse: what it tells us about the inflammatory response. J Physiol Pharmacol 53, 541-553.
23. Sinha, P., Hutter, G., Kottgen, E., Dietel, M., Schadendorf, D., and Lage, H. (1998). Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis and drug resistant human stomach cancer cells. J Biochem Biophys Methods 37, 105-106.
24. Sun, D., Melegari, M., Sridhar, S., Rogler, C.E., and Zhu, L. (2006). Multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. BioTechniques 41, 1-5.
25. Suzuki, H., Ueda, T., Taguchi, H., and Takeuchi, N. (2007). Chaperone properties of mammalian mitochondrial translation elongation factor Tu. J Biol Chem 282, 4076-4084.
26. Szakacs, G., Paterson, J.K., Ludwig, J.A., Booth-Genthe, C., and Gottsman, M.M. (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5, 219-234.
27. Torisawa, Y.S., Kaya, T., Takii, Y., Oyamatsu, D., Nishizawa, M., and Matsue, T. (2003). Scanning electrochemical microscopybased drug sensitivity test for a cell culture integrated in silicon microstructures. Anal Chem 75, 2154-2158.
28. Wang, Y., Cao, J., and Zeng, S. (2003). Development of a K562 multidrug-resistant cell line and study on proteins with altered expression. Shi Yan Sheng Wu Xue Bao 36, 342-346.
29. Wang, Y., Serfass, L., Roy, M.O., Wong, J., Bonneau, A.M., and Georges, E. (2004). Annexin-I expression modulates drug resistance in tumor cells. Biochem Biophys Res Commun 314, 565-570.
30. Wells, J., Henkler, F., Leversha, M., and Koshy, R. (1995). A mitochondrial elongation factor-like protein is over-expressed in tumours and differentially expressed in normal tissues. FEBS Lett 358, 119-125.
31. Xin, W., Rhodes, D.R., Ingold, C., Chinnaiyan, A.M., and Rubin, M.A. (2003). Dysregulation of the annexin family protein is associated with prostate cancer progression. Am J Pathol 162, 255-261.
32. Yang, Y.X., Xiao, Z.Q., Chen, Z.C., Zhang, G.Y., Yi, H., Zhang, P.F., et al. (2006). Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/ VCR. Proteomics 6, 2009-2021.